Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World
Clinical Infectious Diseases · 02.06.2026 · 82 (Supplement_5) · S105-S115
DOI: 10.1093/cid/ciag025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 02.06.2026. Verfasst von Abi Manesh und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Christian Medical College, Vellore, Tamil Nadu, India. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Drug Resistance, Multiple, Bacterial, Gram-Negative Bacteria, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: DBT-Wellcome Trust India Alliance.
Abstract (Originalsprache)
Background
Multidrug-resistant gram-negative bacterial (MDR GNB) infections are associated with high mortality. The evidence base for the management of these infections is weak. Major international bodies have recently offered guidance on managing these infections. Their impact on real-life practice is unknown.
Methods
We conducted an online survey utilizing a 123-item questionnaire among healthcare professionals managing patients with serious MDR GNB infections via national societies and professional networks.
Results
A total of 1320 respondents from 76 countries completed the survey. The primary area of practice was adult infectious diseases (56.2%; 739/1320), followed by clinical microbiology (13.0%; 171/1320). There were significant differences among preferred first-choice agents (assuming all drugs were available) across infection syndromes in all regions (eg, polymyxins as first choice for carbapenem-resistant Enterobacterales [CRE] KPC; 5/381 in high-income countries [HICs] vs 24/390 in the rest of the world; P < .001), but more pronounced in low- and middle-income countries (LMICs). The greatest disparities in antibiotic availability were seen with cefiderocol, ceftolozane–tazobactam, eravacycline, meropenem–vaborbactam, and imipenem–cilastatin–relebactam.
Conclusions
Management practices for carbapenem-resistant gram-negative pneumonia and bacteremia vary widely, complicated by limited access to new antimicrobial agents in the LMICs. Evaluations of the potential impact of these new antimicrobial agents on the outcome of infections in LMICs are urgently needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Christian Medical College, Vellore, Tamil Nadu, India.
- ADVANCE-ID, Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.
- University of Queensland Centre for Clinical Research, Brisbane, Queensland, Australia.
- Infectious Diseases Unit, Department of Medicine, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
- Division of Infectious Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland.
- Division of Infectious Diseases & International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA.
ORCID-Profile: Mithun Mohan George, Helmi Sulaiman, Amy J Mathers, Alexandre P Zavascki, Yin Mo, Dafna Yahav, Emanuele Rando, Tom Boyles, Minggui Wang, Prasannakumar Palanikumar, George M Varghese, David L Paterson
Förderung
- DBT-Wellcome Trust India Alliance
Zitieren
APA
Manesh, A., Aslan, A. T., Mohan George, M., Sulaiman, H., Huttner, A., Mathers, A. J., Zavascki, A. P., Mo, Y., Yahav, D., Rando, E., Boyles, T., Wang, M., Palanikumar, P., Varghese, G. M., & Paterson, D. L. (2026). Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World. Clinical Infectious Diseases, 82(Supplement_5), S105-S115. https://doi.org/10.1093/cid/ciag025
Vancouver
Manesh A, Aslan AT, Mohan George M, Sulaiman H, Huttner A, Mathers AJ, et al. Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World. Clinical Infectious Diseases. 2026;82(Supplement_5):S105-S115. doi:10.1093/cid/ciag025
BibTeX
@article{Manesh2026,
author = {Manesh, Abi and Aslan, Abdullah T and Mohan George, Mithun and Sulaiman, Helmi and Huttner, Angela and Mathers, Amy J and Zavascki, Alexandre P and Mo, Yin and Yahav, Dafna and Rando, Emanuele and Boyles, Tom and Wang, Minggui and Palanikumar, Prasannakumar and Varghese, George M and Paterson, David L},
title = {Global Survey on the Management of Multidrug-resistant Gram-negative Bacilli: Divergence of Practice Between High-Income Countries and the Rest of the World},
journal = {Clinical Infectious Diseases},
year = {2026},
volume = {82},
number = {Supplement_5},
pages = {S105--S115},
doi = {10.1093/cid/ciag025}
}
EUVIMED